Cloning and identification of a novel cDNA coding thioredoxin-related transmembrane protein 2

Biochemical Genetics

Volumn 41, Issue 3-4, 2003, Pages 99-106

  Meng, Xianfang ^a,b   Zhang, Chun ^c   Chen, Jinzhong ^a   Peng, Shuying ^d   Cao, Yaoqiong ^a   Ying, Kang ^a   Xie, Yi ^a   Mao, Yumin ^a  

^a FUDAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Union Hospital   (China)

^d Department of Medicine   (China)

Author keywords

Northern blot; Thioredoxin TMX2

Indexed keywords

COMPLEMENTARY DNA; MEMBRANE PROTEIN; NUCLEOTIDE; PROTEIN TMX 2; THIOREDOXIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; DNA DETERMINATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN TISSUE; ISOELECTRIC POINT; MOLECULAR CLONING; MOLECULAR WEIGHT; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN ANALYSIS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BASE SEQUENCE; BINDING SITES; BLOTTING, NORTHERN; CELL MEMBRANE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS V-MYB; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; THIOREDOXIN;

EID: 0038296107     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022073917044     Document Type: Article

References (21)

1. Didier, C., Pouget, J. P., Cadet, J., Favier, A., Beani, J. C., and Richard, M. J. (2001). Modulation of exogenous and endogenous levels of thioredoxin in human skin fibroblasts prevents DNA damaging effect of ultraviolet A radiation. Free Radic. Biol. Med. 30(5):537.
2. Harding, H. P., Zhang, Y., and Ron, D. (1999). Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397(6716):271.
3. Hata, I., Shigematsu, Y., Ohshima, Y., Tsukahara, H., Fujisawa, K., Hiraoka, M., Nakamura, H., Masutani, H., Yodoi, J., Kotsuji, F., Sudo, M., and Mayumi, M. (2001). Involvement of thioredoxin in the regulation of growth hormone secretion in rat pituitary cell cultures. Am. J. Physiol. Endocrinol. Metab. 281(2):E269.
4. Holmgren, A. (1985). Thioredoxin. Annu. Rev. Biochem. 54:237.
5. Holmgren, A. (1989). Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264(24):13963.
6. Horowitz, D. S., and Krainer, A. R. (1994). Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet. Mar. 10(3):100-106. R.
7. Kobayashi, M., Nakamura, H., Yodoi, J., and Shiota, K. (2000). Immunohistochemical localization of thioredoxin and glutaredoxin in mouse embryos and fetuses. Antioxid. Redox. Signal 2(4):653.
8. Marian, A. J., and Roberts, R. (1993). Molecular genetics of cardiomyopathies. Herz 18(4):230.
9. Matsuo, Y., Akiyama, N., Nakamura, H., Yodoi, J., Noda, M., and Kizaka-Kondoh, S. (2001). Identification of a novel thioredoxin-related transmembrane protein. J. Biol. Chem. 276(13):10032.
10. Miranda-Vizuete, A., Ljung, J., Damdimopoulos, A. E., Gustafsson, J. A., Oko, R., Pelto-Huikko, M., and Spyrou, G. (2001). Characterization of Sptrx, a novel member of the thioredoxin family specifically expressed in human spermatozoa. J. Biol. Chem. 276(34):31567.
11. Nakamura, H., De Rosa, S. C., Yodoi, J., Holmgren, A., Ghezzi, P., Herzenberg, L. A., and Herzenberg, L. A. (2001). Chronic elevation of plasma thioredoxin: Inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc. Natl. Acad. Sci. U.S.A. 98(5):2688.
12. Noda, N., Ochiai, A., Miyazaki, K., Sugimura, T., Terada, M., and Wakasugi, H. (2000). Detection of thioredoxin in gastric cancer: Association with histological type. Antioxid. Redox. Signal. 2(3):519.
13. Noiva, R., and Lennarz, W. J. (1992) Protein disulfide isomerase. A multifunctional protein resident in the lumen of the endoplasmic reticulum. J. Biol. Chem. 267(6):3553.
14. Packer, L., and Yodoi, J. (eds.) (1999). Redox Regulation of Cell Signaling and Its Clinical Application, Marcel Dekker, New York, pp. 251-277.
15. Sidrauski, C., Chapman, R., and Walter, P. (1998). The unfolded protein response: An intracellular signalling pathway with many surprising features. Trends Cell Biol. 8(6):245.
16. Soini, Y., Kahlos, K., Napankangas, U., Kaarteenaho-Wiik, R., Saily, M., Koistinen, P., Paaakko, P., Holmgren, A., and Kinnula, V. L. (2001). Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin. Cancer Res. 7(6):1750.
17. Stephens, R. M., and Schneider, T. D. (1992). Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites. J. Mol. Biol. 228(4):1124.
18. Ueno, M., Masutani, H., Arai, R. J., Yamauchi, A., Hirota, K., Sakai, T., Inamoto, T., Yamaoka, Y., Yodoi, J., Sakai, T., and Nikaido, T. (1999). Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 274(50):35809.
19. Wakasugi, H., Wakasugi, N., Tursz, T., Tagaya, Y., and Yodoi, J. (1989). Production of an IL-1-like factor by 3B6 EBV-infected B cells. J. Immunol. 142(7):2569.
20. Werner, M., Nolte, M., Kaloutsi, V., Buhr, T., Kausche, F., and Georgii, A. (1995). Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders. Lab. Invest. 72(4):405.
21. Zimonjic, D. B., Keck, C. L., Thorgeirsson, S. S., and Popescu, N. C. (1999). Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology 29(4):1208.